Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #4,111 to #4,160.
- TXNDC4 (1 revision)
- TXNDC5 (1 revision)
- TXNDC9 (1 revision)
- TXNL1 (1 revision)
- TXNL4A (1 revision)
- TXNRD1 (1 revision)
- T cell receptor (1 revision)
- T helper 17 cell (1 revision)
- T helper cell (1 revision)
- Tabebuia alba (1 revision)
- Table of United States Combined Statistical Areas (1 revision)
- Table of nuclides (1 revision)
- Tablespoon (1 revision)
- Tablet (1 revision)
- Tachycardia mediated heart failure (1 revision)
- Tachypnea (patient information) (1 revision)
- Tachypnea case study one (1 revision)
- Tachypnea chest x ray (1 revision)
- Tachypnea cost-effectiveness of therapy (1 revision)
- Tachypnea epidemiology and demographics (1 revision)
- Tachypnea future or investigational therapies (1 revision)
- Tachypnea natural history (1 revision)
- Tachypnea other diagnostic studies (1 revision)
- Tachypnea other imaging findings (1 revision)
- Tachypnea pathophysiology (1 revision)
- Tachypnea physical examination (1 revision)
- Tachypnea primary prevention (1 revision)
- Tachypnea risk factors (1 revision)
- Tachypnea secondary prevention (1 revision)
- Tachypnea surgery (1 revision)
- Tacrine (patient information) (1 revision)
- Tacrolimus topical (patient information) (1 revision)
- Tacticity (1 revision)
- Tadalafil (patient information) (1 revision)
- Tadocizumab (1 revision)
- Taenia (tapeworm) (1 revision)
- Taeniacide (1 revision)
- Tafamidis (1 revision)
- Tafasitamab-cxix (1 revision)
- Taft equation (1 revision)
- Taho (1 revision)
- Tai Ji (1 revision)
- Tai chi classics (1 revision)
- Taijin kyofusho (1 revision)
- Tak Wah Mak (1 revision)
- Takai olefination (1 revision)
- Talastine (1 revision)
- Talineuzumab (1 revision)
- Talipexole (1 revision)
- Talizumab (1 revision)